Cargando…

608. Systematic Fungal Biomarker Testing in Lung Transplant Recipients : Retrospective Analysis to Optimize Their Use

BACKGROUND: Serial galactomannan (GM), 1,3-β-d-glucan (BDG) and Pneumocystis jirovecii (PJ) testing after lung transplantation are resource consuming and have low PPV for invasive fungal infections (IFI) in asymptomatic recipients. METHODS: We aim to document the added-value of mentioned reflex scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutin, Catherine-Audrey, Ison, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678285/ http://dx.doi.org/10.1093/ofid/ofad500.674

Ejemplares similares

1737. Impact of Therapeutic Drug Monitoring (TDM) of Azole Prophylaxis in Lung Transplant Recipients on the Development of Positive Fungal Events
por: Shah, Anooj, et al.
Publicado: (2019)

1771. Donor-derived Ureaplasma Infection Increases Mortality in Lung Transplant Recipients
por: Roberts, Scott C, et al.
Publicado: (2019)

2706. Effectiveness and Safety of Shingrix Vaccination in Solid Organ Transplant Recipients at a Large Urban Transplant Center
por: Halkett, Megan, et al.
Publicado: (2023)

2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes
por: Kovac, Victor, et al.
Publicado: (2023)

Fungal thyroiditis in a lung transplant recipient
por: King, Christopher, et al.
Publicado: (2018)

608. The Effect of Prenatal Screening for Chlamydia trachomatis (CT) on Chlamydial Conjunctivitis in Infants
por: Banniettis, Natalie, et al.
Publicado: (2018)

2716. Epidemiology of invasive fungal infection in pediatric liver transplant recipients: A retrospective, single-center study, 2012-2022
por: Lee, Ji Young, et al.
Publicado: (2023)

Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors
por: Boutin, Catherine-Audrey, et al.
Publicado: (2023)

1133. Epidemiology of Invasive Fungal Infections in Lung Transplant Recipients: Harnessing Data Mining Tools to Build a Comprehensive Database
por: Yek, Christina, et al.
Publicado: (2018)

608. Evaluation of Safety of High-Dose Beta-Lactam Antibiotics in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
por: Varona, Jerald, et al.
Publicado: (2022)

782. Infectious Complications of Lung Transplant for COVID-Associated Lung Injury (CALI)
por: Osborn, Rebecca, et al.
Publicado: (2022)

Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients
por: Escamilla, Jesus E., et al.
Publicado: (2023)

1739. Epidemiology of Invasive Fungal Infections in Allogenic Hematopoietic Stem Cell Transplant Recipients in Utah
por: Zurko, Jessica, et al.
Publicado: (2019)

608. Emerging Methicillin Resistance Mechanism in mec Gene-Negative Staphylococci not Detected by Reference Methods
por: Durand, Geraldine, et al.
Publicado: (2019)

540. Prolonged Viral Shedding of SARS-CoV-2 In Solid Organ Transplant Recipients
por: Nam, Hannah, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
por: Boutin, Catherine-Audrey, et al.
Publicado: (2023)

PT608. Analysis of glutamate-induced processing of proline-rich transmembrane protein 2 (PRRT2)
por: Hatta, Daisuke, et al.
Publicado: (2016)

195. Economic and Clinical Burden of Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
por: Ison, Michael G, et al.
Publicado: (2020)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

2728. Bronchial Cultures at Time of Transplant Affect Anastomotic Outcomes in Lung Transplant Recipients
por: Veisblatt, Jesse, et al.
Publicado: (2023)

1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
por: Friedman, Daniel, et al.
Publicado: (2019)

The Prediction and Prognosis of Fungal Infection in Lung Transplant Recipients—A Retrospective Cohort Study in South Korea
por: Baek, Yae-Jee, et al.
Publicado: (2021)

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

1136. Universal Prophylaxis for Prevention of Invasive Aspergillus in Lung Transplant Recipients
por: Guenette, Alexis, et al.
Publicado: (2018)

608. Continuous Infusion Vancomycin Is Not Associated with Improved Safety in an Outpatient Parenteral Antimicrobial Therapy Program
por: Tagare, Rosemarie D, et al.
Publicado: (2021)

1138. Retrospective Cohort Analysis of Amphotericin B Nephrotoxicity in Kidney Transplant Recipients
por: Assi, Mariam, et al.
Publicado: (2018)

Fungal Infections in Liver Transplant Recipients
por: Scolarici, Michael, et al.
Publicado: (2021)

2044. Utility of Serum Β-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2018)

2736. Real-world Effectiveness of Posaconazole Prophylaxis in Preventing Invasive Fungal Infections in Recipients of Allogeneic Stem Cell Transplantation
por: Álvarez-Ortega, Carolina, et al.
Publicado: (2023)

Epidemiology and Prognosis of Invasive Fungal Disease in Chinese Lung Transplant Recipients
por: Ju, Chunrong, et al.
Publicado: (2021)

Fungal Tracheobronchitis in Lung Transplant Recipients: Incidence and Utility of Diagnostic Markers
por: Hammarström, Helena, et al.
Publicado: (2022)

783. Lung Transplantation for COVID-19-Associated Lung Injury (CALI): An International Registry
por: Alamri, Maha M, et al.
Publicado: (2022)

1023. Host Gene Expression Biomarkers to Distinguish Between Causes of Acute Respiratory Symptoms in Lung Transplant Recipients
por: Steinbrink, Julie M, et al.
Publicado: (2021)

2117. Outcomes and Risk Factors Associated with Development of Pneumonia in Lung Transplant Recipients in the Year After Transplant
por: Gallagher, Jason C, et al.
Publicado: (2022)

Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017)

2138. Impact of De-escalation of Antibiotic Surgical Prophylaxis in Lung Transplant Recipients
por: Gandotra, Sumit, et al.
Publicado: (2018)

2732. Peri-Operative Antibiotic Management for Lung Transplant Recipients with Cystic Fibrosis
por: Gordon, Melissa, et al.
Publicado: (2023)

262. COVID-19 associated fungal co-infections in Solid Organ Transplant Recipients: A single center case series
por: Khatri, Akshay M, et al.
Publicado: (2022)

1571. Cost-Effectiveness Analysis of Duration of Valganciclovir Prophylaxis Among CMV Serology Mismatched (Donor+/Recipient−) Lung Transplant Recipients
por: Tomko, Heather, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9i3ahrbau40d2d9j36rkqdg1df